Takeda Pharmaceutical Company Limited Adjustments For Increase Decrease In Trade And Other Payables
Takeda Pharmaceutical Company Limited (TAK) reported Adjustments For Increase Decrease In Trade And Other Payables of -JPY 7.12 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2025-06-25
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|
| 2025-03-31 | -7.12B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -9.89B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -84.80B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 125.16B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 36.62B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -29.93B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -16.41B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 6.86B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 42.56B JPY 20-F · filed 2019-06-27 |